Literature DB >> 27171650

Orbital Recurrence following Aggressive Laser Treatment for Recurrent Retinoblastoma.

Bradley H Jacobsen1, Jesse L Berry2, Rima Jubran3, Jonathan W Kim2.   

Abstract

PURPOSE: To report a case of a 29-month-old male with familial, bilateral retinoblastoma with orbital recurrence following aggressive laser treatment.
METHODS: This is a retrospective case report of a single patient.
RESULTS: A 3-week-old male was diagnosed with familial, bilateral retinoblastoma (group D OD, group A OS), and treated with 6 cycles of systemic chemotherapy and laser treatment. The patient exhibited full regression of tumors in both eyes. Two years after diagnosis, a small tumor recurrence within the macular laser scar of the right eye was discovered. The tumor recurrence was treated with argon and diode laser over 6 months. The tumor recurrence completely resolved following the laser treatments. Ten weeks after the last laser treatment, MRI revealed a large intraconal orbital mass, contiguous with the sclera of the right eye. Orbital biopsy and systemic work-up confirmed the diagnosis of retinoblastoma with no other metastatic foci. B-scan ultrasonography showed thinning of the sclera at the site of recurrence.
CONCLUSION: This is an unusual orbital recurrence after successful treatment of intraocular disease with aggressive laser therapy. Clinicians should be aware of the rare possibility of orbital recurrence following chemoreduction with local consolidation even when fundus examinations are normal.

Entities:  

Keywords:  Argon laser; Diode laser; Focal therapy; Oncology; Retinoblastoma; Tumor recurrence

Year:  2015        PMID: 27171650      PMCID: PMC4847708          DOI: 10.1159/000439055

Source DB:  PubMed          Journal:  Ocul Oncol Pathol        ISSN: 2296-4657


  8 in total

1.  Vitrectomy in eyes with unsuspected retinoblastoma.

Authors:  C L Shields; S Honavar; J A Shields; H Demirci; A T Meadows
Journal:  Ophthalmology       Date:  2000-12       Impact factor: 12.079

2.  Vitreoretinal complications of retinoblastoma treatment.

Authors:  Khaled A Tawansy; Michael A Samuel; Maya Shammas; A Linn Murphree
Journal:  Retina       Date:  2006-09       Impact factor: 4.256

3.  Orbital recurrence of retinoblastoma following enucleation.

Authors:  J W Kim; V Kathpalia; I J Dunkel; R K Wong; E Riedel; D H Abramson
Journal:  Br J Ophthalmol       Date:  2008-08-29       Impact factor: 4.638

4.  Local extraocular extension of retinoblastoma following intraocular surgery.

Authors:  K E Stevenson; J Hungerford; A Garner
Journal:  Br J Ophthalmol       Date:  1989-09       Impact factor: 4.638

5.  Tumor seeding in ocular fine needle aspiration biopsy.

Authors:  Z A Karcioglu; R A Gordon; G L Karcioglu
Journal:  Ophthalmology       Date:  1985-12       Impact factor: 12.079

6.  Vitreous relapse following primary chemotherapy for retinoblastoma: is adjuvant diode laser a risk factor?

Authors:  D S Gombos; P A Cauchi; J L Hungerford; P Addison; P G Coen; J E Kingston
Journal:  Br J Ophthalmol       Date:  2006-05-17       Impact factor: 4.638

7.  Focal therapy in the management of retinoblastoma: when to start and when to stop.

Authors:  P Hamel; E Heon; B L Gallie; A S Budning
Journal:  J AAPOS       Date:  2000-12       Impact factor: 1.220

Review 8.  Pediatric tumors of the eye and orbit.

Authors:  Bienvenido V Castillo; Lawrence Kaufman
Journal:  Pediatr Clin North Am       Date:  2003-02       Impact factor: 3.278

  8 in total
  2 in total

1.  Risk of metastasis and orbital recurrence in advanced retinoblastoma eyes treated with systemic chemoreduction versus primary enucleation.

Authors:  Jesse L Berry; Kaitlin Kogachi; Hassan A Aziz; Kathleen McGovern; Emily Zolfaghari; A Linn Murphree; Rima Jubran; Jonathan W Kim
Journal:  Pediatr Blood Cancer       Date:  2016-11-05       Impact factor: 3.167

Review 2.  A Review of Recurrent Retinoblastoma: Children's Hospital Los Angeles Classification and Treatment Guidelines.

Authors:  Jesse L Berry; Kaitlin Kogachi; A Linn Murphree; Rima Jubran; Jonathan W Kim
Journal:  Int Ophthalmol Clin       Date:  2019
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.